Rogerj Pomerantz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rogerj pomerantz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rogerj Pomerantz Today - Breaking & Trending Today

Yonkers' ContraFect Corp. posts $7.6M Q2 net loss - Westfair Communications

ContraFect Corp. (NASDAQ: CFRX), a Yonker-headquartered clinical-stage biotechnology company focused on developing new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, reported a net loss was $7.6 million, or a loss of $1.94 per share, for the second quarter. ....

Rogerj Pomerantz , Contrafect Corp ,

ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update

ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United States , Rogerj Pomerantz , Michael Messinger , Exchange Commission On , Contrafect Corporation Nasdaq , Company Annual Report On Form , Contrafect Corporation , Exchange Commission , Fect Corporation , Chief Executive Officer , Coagulase Negative Staphylococci , Breakthrough Therapy , Nasdaq Capital Markets , Quarterly Report , Months Ended June , Accepted Accounting Principles , Annual Report , Quarterly Reports , Relations Contacts ,

ContraFect Data Presentations at ASM Microbe 2023 Demonstrate the Power of the Company's Proprietary Platform to Discover New Agents Targeting Antibiotic-Resistant Gram-negative Pathogens

ContraFect Data Presentations at ASM Microbe 2023 Demonstrate the Power of the Company's Proprietary Platform to Discover New Agents Targeting Antibiotic-Resistant Gram-negative Pathogens
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United States , Rogerj Pomerantz , Michael Messinger , Exchange Commission , Contrafect Corporation Nasdaq , Drug Administration Antibiotic Resistance Isolate Bank , Contrafect Corporation , Chief Executive Officer , Disease Control , Coagulase Negative Staphylococci , Annual Report , Relations Contacts ,

ContraFect (CFRX) Provides Update from the Futility Analysis of the Phase 3 DISRUPT Study of Exebacase

ContraFect (CFRX) Provides Update from the Futility Analysis of the Phase 3 DISRUPT Study of Exebacase
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Michael Messingercontrafect Corporationtel , Garrett Nichols , Contrafect Dlas , Rogerj Pomerantz , Us Department Of Health , Human Services , Biomedical Advanced Research , Contrafect Corporation , Administration For Strategic Preparedness , Development Authority , Exchange Commission , Contrafect Corporation Nasdaq , Wall Street , Fect Corporation , Direct Lysis , Resistant Pathogen Trial , Futility Dataset , Exebacase Arm , Chief Executive Officer , Interim Chief Medical , Data Safety Monitoring Board , Breakthrough Therapy , Strategic Preparedness , Looking Statements , Quarterly Report ,

ContraFect (CFRX) Announces ANSM Approval of Clinical Trial Application for Exebacase in Prosthetic Joint Infections

ContraFect (CFRX) Announces ANSM Approval of Clinical Trial Application for Exebacase in Prosthetic Joint Infections
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Rogerj Pomerantz , Contrafect Corporation Nasdaq , Health Products , Wall Street , Fect Corporation , French National Agency , Clinical Trial Application , Coagulase Negative Staphylococci , Chief Executive Officer ,